Marken Ltd (Marken) is a clinical supply chain solution provider that offers logistics and support services to the clinical trial, life sciences and pharmaceutical industries. The company provides medical devices delivery, shipment lane qualifications, biological sample shipments, biological kit production, storage and distribution, ancillary material sourcing and direct to patient services. It offers value added services such as regulatory, trade compliance and customs consultancy; white glove services and temperature controlled packaging solutions. Marken depot network provide project management, re-labeling, drug return and destruction services. It operates in the Americas, Middle East, South Africa, Asia, Europe and Australia. Marken is headquartered in London, England, the UK.
Marken Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Summary Basilea Pharmaceutica Ltd (Basilea) is a biopharmaceutical company that develops and markets antibiotics, antifungals and oncology drugs.The company’s products address increasing resistance and non-response to present treatment options for various therapeutic areas such as cancer, bacterial infections and fungal...
Summary Norgine BV (Norgine) is a pharmaceutical company that offers medicinal products.The company develops drugs in the therapeutic areas of gastroenterology, incontinence, hepatology and critical and supportive care and pain management, among others. It offers the treatment of diseases related to gastrointestinal...
Summary Shimadzu Corp (Shimadzu) is a manufacturer of precision instruments, measuring instruments and medical equipment.The company’s product portfolio includes high performance liquid chromatographs (HPLC), spectrometers, carbon analyzer, X-ray systems, inspection systems, semiconductor manufacturing equipment, liquid...
Summary InDex Pharmaceuticals Holding AB (InDex Pharmaceuticals) is a pharmaceutical company that offers treatments for immunological diseases.The company’s lead compound cobitolimod, currently in the phase 2 stage, is intended for the treatment of moderate to severe treatment active refractory ulcerative colitis. Its...
Summary European Molecular Biology Laboratory (EMBL) is a research institution that offers bioinformatics services.The institute’s bioinformatics services include high-throughput sequencing, gene analysis, microscopy, phylogeny, gene expression, protein function analysis, sequence analysis, structural analysis, systems...
Summary NeuroDerm Ltd (NeuroDerm), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a pharmaceutical company that develops of drugs for the treatment of Parkinson’s disease and central nervous system (CNS) disorders through proprietary reformulations of its existing drugs.The company’s liquid formulation of levodopa/carbidopa...